Cell3iMager Estier

Estier is a stage-top optical coherence tomography (OCT) instrument that allows non-invasive analysis of the 3D structures including spheroids, organoids, tubular structures etc. As OCT provides an advantageous platform to visualize the in vitro dynamics of the 3D spheroids conveniently, it can be used as an alternative visualization/monitoring method to obtain quantitative information about the morphological changes occur in 3D cell culture samples.

Cell3iMager Neo

With the Cell3iMager Neo, SCREEN now offers the fastest spheroid-optimized bright field imager at a price every lab can afford. In less than 2 minutes per plate, Neo rapidly determines diameter, area, pseudo volume, and circularity of individual spheroids, non-invasively. The companion 3D optimized analysis software allows faster image capture, measurement and data analysis. Compatible with all major cell culture plates.

 

Cell3iMager Duos

Cell3iMager Duos is designed to overcome the throughput limitations as well as complexities of microscopy. Duos enables simple growth and morphological profiling to more complex analyses such as fluorescence imaging, Z-stacking/focus-bracketing, high-resolution image capturing, and long-term live cell imaging. With Duos you can escape speed and throughput limitations and can focus more on your data. Compatible with all major 2D & 3D cell culture platforms.

Why Screen?

SCREEN – fit your needs, fit your future

SCREEN Holdings Co., Ltd. is one of world’s largest manufacturing company with numerous market leading products. SCREEN founded its Life Science branch ‘SCREEN-Biosciences & Pharmaceuticals’ to help biomedical research community in their quest to discover more effective therapeutic options for patients. SCREEN delivers a comprehensive portfolio of imaging devices and software solutions to support preclinical drug discovery and development studies. SCREEN’s translational imaging and image analysis solutions enables the researchers to image phenotypic changes in cells grown in either 2D or 3D culture settings, within a matter of minutes which could otherwise take weeks to perform.

Building on a history that stretches back to its foundation in 1868, Dainippon Screen Mfg. Co., Ltd. made a new start as SCREEN Holdings Co., Ltd. in October 2014. Over the past 148 years, our commitment to continuously meeting evolving needs has enabled us to grow into a global enterprise employing nearly 10,000 people worldwide.

With its Cell3iMager series SCREEN provides simple, high-throughput, and non-invasive solutions specifically to simplify and accelerate quantitative and qualitative measurement of 3D spheroids and organoids.

Learn More About Screen

“The SCREEN Cell3iMager has become an important part of our MCTS studies, expediting data acquisition and analysis of tumor spheroids over time in a label- free assay setup. The utility of any instrument is partly dependent upon the quality of its support and maintenance, which have been conducted promptly and professionally since purchasing our imager.”

“The SCREEN Cell3iMager has become an important part of our MCTS studies, expediting data acquisition and analysis of tumor spheroids over time in a label- free assay setup. The utility of any instrument is partly dependent upon the quality of its support and maintenance, which have been conducted promptly and professionally since purchasing our imager.”

“The SCREEN Cell3iMager has become an important part of our MCTS studies, expediting data acquisition and analysis of tumor spheroids over time in a label- free assay setup. The utility of any instrument is partly dependent upon the quality of its support and maintenance, which have been conducted promptly and professionally since purchasing our imager.”

Need help finding the right product?

Call us at +1 (847) 870-7400.

Our imaging experts will walk you through the your options.